BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2012
View Archived Issues
Researchers at Acceleron Pharma patent new fusion proteins for cancer
Read More
First-in-man continuous levodopa/carbidopa study begins enrollment
Read More
Research collaboration for rare pediatric diseases established
Read More
PlGF as a novel biomarker for risk assessment in patients with light-chain amyloidosis
Read More
Nymox to commence study evaluating repeat injections of NX-1207
Read More
Recently reported data support phase II study of ALS-2200
Read More
Phase III perindopril/amlodipine fixed-dose combination study meets primary endpoint
Read More
Taiho presents data on TAS-2985, a novel inhibitor of FGFR
Read More
Antisense oligonucleotide drug targets alpha-1-antitrypsin deficiency
Read More
Bridged nucleic acid technology improves hypertriglyceridemia in mice
Read More
Klotho promoter hypermethylation linked to survival in glioblastoma multiforme
Read More
French group presents new agents for CML
Read More
Numedicus synthesizes novel AMPA receptor agonists
Read More
Scientists at Daiichi Sankyo prepare new 11-beta-HSD1 inhibitors
Read More
Adamed divulges novel fusion proteins for cancer
Read More
Researchers at Pfizer present new acetyl-CoA carboxylase inhibitors
Read More
New monoclonal antibodies for cancer presented by U.S. researchers
Read More
Paladin Labs launches sublingual grass pollen immunotherapy tablet in Canada
Read More
Novel agents for tuberculosis patented by GlaxoSmithKline
Read More
Botox approved for severe primary axillary hyperhidrosis in Japan
Read More
Everolimus approved in new TSC indications in Japan
Read More
Phase IIa trial begins of MediciNova's ibudilast
Read More
Pfizer launches Tygacil in Japan
Read More
Recruitment begins in pivotal phase IIb trial of GFT-505
Read More
FDA orphan drug designation granted to OXi-4503
Read More
EMA to begin formal review of macitentan MAA
Read More